Researchers with City of Hope and MSK have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient’s likely response to chimeric antigen receptor (CAR) T cell therapy before starting the treatment, according to study results published in Nature Medicine.
City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States and a top research center for diabetes and other life-threatening illnesses, is leading a phase 1/2 clinical trial investigating an osteoporosis medication as a way to improve beta cell health in people with early type 1 diabetes.
Culver City-based ImmunityBio, Inc., a leading immunotherapy company, has announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for the company’s ANKTIVA and CAR-NK (PD-L1 t-haNK) for the reversal of Lymphopenia in patients receiving standard-of-care chemotherapy/radiotherapy and in multiply relapsed locally advanced or metastatic pancreatic cancer.
Agoura Hills-based biotech firm Acelyrin Inc. agreed to merge with San Francisco-based Alumis Inc. in a deal valued at $320 million on February 6.
Beverly Hills-based Nordicus Partners Corp. entered into a stock purchase and sale agreement to acquire Bio-Convert ApS for $60.6 million on November 11.
Irvine-headquartered Edwards Lifesciences has successfully completed the sale of its Critical Care product group to BD (Becton, Dickinson and Company) for $4.2 billion in an all-cash transaction.
PharmaLogic, a contract development and manufacturing organization (CDMO) and radiopharmacy solutions provider, has announced the official opening of its radiopharmaceutical production and research facility in Los Angeles, according to a press release.
City of Hope has received a historic $150-million gift from entrepreneurs and philanthropists A. Emmet Stephenson Jr. and his daughter Tessa Stephenson Brand to immediately fund pancreatic cancer research.
New Keck Medicine of USC research published in Advances in Wound Care suggests there may be a more effective method to detect bacteria during wound debridement.
City of Hope Orange County, part of one of the largest cancer research and treatment organizations in the United States, has announced that world-renowned colorectal surgeon Alessio Pigazzi, M.D., Ph.D., has joined the organization as clinical professor of surgery, executive medical director of colorectal surgery and vice chair of clinical network affairs for the Department of Surgery.
